Lv7
4610 积分 2022-04-21 加入
Expert consensus on clinical trials for use of systemic therapy in patients with hepatocellular carcinoma undergoing surgical and locoregional therapies
5天前
已关闭
The decade that changed hepatocellular carcinoma: shaping a new treatment paradigm
1个月前
已关闭
Precision oncology in primary liver cancer: bridging the gap between molecular profiling and patient benefit
5个月前
已关闭
Immune Checkpoint Inhibitor–Associated Cardiovascular Toxic Effects
5个月前
已完结
Immune Checkpoint Inhibitor–Associated Myocarditis: Current Understanding of Clinical Presentation and Management
5个月前
已完结
The global epidemiology of hepatocellular carcinoma
5个月前
已完结
Hepatocellular carcinoma: Clinical trials to watch
6个月前
已完结
Nivolumab plus ipilimumab for hepatocellular carcinoma: a game-changer?
6个月前
已完结
British Society of Gastroenterology endorsed guidance for the management of immune checkpoint inhibitor-induced enterocolitis
7个月前
已完结
Integrating Quality of Life and Survival in Systemic Therapy for Advanced Hepatocellular Carcinoma
7个月前
已完结
皖公网安备34019202002308
